Thymus-derived, peripherally derived, and in vitro-induced T regulatory cells

Frontiers in Immunology

Volumn 5, Issue JAN, 2014, Pages

  Elkord, Eyad ^a,b,c  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF SALFORD   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Autoimmune diseases; Cancer; GvHD; Induced tregs; Infection; Peripherally derived; Thymus derived

Indexed keywords

ADENOSINE; CYTOKINE; INTERLEUKIN 2; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; DENDRITIC CELL; EDITORIAL; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HEPATITIS B; HUMAN; INFLAMMATORY DISEASE; NEOPLASM; NONHUMAN; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TUMOR MICROENVIRONMENT;

EID: 84895533660     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00017     Document Type: Editorial

References (21)

1. Kitagawa Y, Ohkura N, Sakaguchi S. Molecular determinants of regulatory T cell development: the essential roles of epigenetic changes. Front Immunol (2013) 4:106. doi: 10.3389/fimmu.2013.00106.
2. Povoleri GA, Scotta C, Nova-Lamperti EA, John S, Lombardi G, Afzali B. Thymic versus induced regulatory T cells-who regulates the regulators? Front Immunol (2013) 4:169. doi:10.3389/fimmu.2013.00169.
3. Dhamne C, Chung Y, Alousi AM, Cooper LJ, Tran DQ. Peripheral and thymic foxp3(+) regulatory T cells in search of origin, distinction, and function. Front Immunol (2013) 4:253. doi:10.3389/fimmu.2013.00253.
4. Goldstein JD, Perol L, Zaragoza B, Baeyens A, Marodon G, Piaggio E. Role of cytokines in thymus-versus peripherally derived-regulatory T cell differentiation and function. Front Immunol (2013) 4:155. doi:10.3389/fimmu.2013.00155.
5. Schmitt EG, Williams CB. Generation and function of induced regulatory T cells. Front Immunol (2013) 4:152. doi:10.3389/fimmu.2013.00152.
6. Yamazaki S, Morita A. Dendritic cells in the periphery control antigen-specific natural and induced regulatory T cells. Front Immunol (2013) 4:151. doi:10.3389/fimmu.2013.00151.
7. Adeegbe DO, Nishikawa H. Natural and induced T regulatory cells in cancer. Front Immunol (2013) 4:190. doi:10.3389/fimmu.2013.00190.
8. Burocchi A, Colombo MP, Piconese S. Convergences and divergences of thymus-and peripherally derived regulatory T cells in cancer. Front Immunol (2013) 4:247. doi:10.3389/fimmu.2013.00247.
9. Ondondo B, Jones E, Godkin A, Gallimore A. Home sweet home: the tumor microenvironment as a haven for regulatory T cells. Front Immunol (2013) 4:197. doi:10.3389/fimmu.2013.00197.
10. Wainwright DA, Dey M, Chang A, Lesniak MS. Targeting Tregs in malignant brain cancer: overcoming IDO. Front Immunol (2013) 4:116. doi:10.3389/fimmu.2013.00116.
11. Darrasse-Jeze G, Podsypanina K. How numbers, nature, and immune status of Foxp3 regulatory T-cells shape the early immunological events in tumor development. Front Immunol (2013) 4:292. doi:10.3389/fimmu.2013.00292.
12. Beres AJ, Drobyski WR. The role of regulatory T cells in the biology of graft versus host disease. Front Immunol (2013) 4:163. doi:10.3389/fimmu.2013.00163.
13. Yadav M, Stephan S, Bluestone JA. Peripherally induced tregs-role in immune homeostasis and autoimmunity. Front Immunol (2013) 4:232. doi:10.3389/fimmu.2013.00232.
14. Hall BM, Tran GT, Verma ND, Plain KM, Robinson CM, Nomura M, et al. Do natural T regulatory cells become activated to antigen specific T regulatory cells in transplantation and in autoimmunity? Front Immunol (2013) 4:208. doi:10.3389/fimmu.2013.00208.
15. 3+ regulatory T-cell subsets in human immunodeficiency virus infection. Front Immunol (2013) 4:215. doi:10.3389/fimmu.2013.00215.
16. 3 and PD1/PDL1 expression is down-regulated in chronic HBV hepatitis on maintained remission related to the degree of inflammation. Front Immunol (2013) 4:207. doi:10.3389/fimmu.2013.00207.
17. Metenou S, Nutman TB. Regulatory T cell subsets in filarial infection and their function. Front Immunol (2013) 4:305. doi:10.3389/fimmu.2013.00305.
18. Ng TH, Britton GJ, Hill EV, Verhagen J, Burton BR, Wraith DC. Regulation of adaptive immunity; the role of interleukin-10. Front Immunol (2013) 4:129. doi:10.3389/fimmu.2013.00129.
19. Olson BM, Sullivan JA, Burlingham WJ. Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance. Front Immunol (2013) 4:315. doi:10.3389/fimmu.2013.00315.
20. Whiteside TL, Jackson EK. Adenosine and prostaglandin e2 production by human inducible regulatory T cells in health and disease. Front Immunol (2013) 4:212. doi:10.3389/fimmu.2013.00212.
21. 4 T cells identifies maximal cytokine-producing effectors. Front Immunol (2013) 4:233. doi:10.3389/fimmu.2013.00233.